Richard /ca/ Murray, CEO and President at Jounce Therapeutics, Inc. (JNCE), sold 32,182 shares at $6.76 ($220K) on 2021-01-07, disclosed to the SEC on 2021-01-11.
Open-market sale of $220k JNCE by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.76 | 10,183 | $69K | 31.2% |
| 2 | $6.76 | 10,183 | $69K | 31.2% |
| 3 | $7.00 | 11,816 | $83K | 37.5% |
| Total | $6.85 avg | 32,182 | $220K | 100% |
| Filing → |
| JNCE | SELL | 2022-01-11 | $416K | — | Filing → |
| JNCE | SELL | 2021-01-25 | $808K | — | Filing → |
| JNCE | SELL | 2021-01-20 | $1.3M | — | Filing → |